Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2023-12-22

Clinical Trial Update: The Effect of Nitroglycerin Infusion Rate on Cerebral Rewarming During Hypothermic Coronary Artery Bypass Grafting [Phase 4]

View source ↗

Summary

Phase 4 trial investigating how nitroglycerin infusion rate affects cerebral rewarming during hypothermic coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NITROGLYCERIN (Nitroglycerin)

Snippet

Sponsor: Recep Tayyip Erdogan University | Conditions: Coronary Artery Bypass, Cardiopulmonary Bypass | Phase 4 | Status: COMPLETED